학술논문

Molecular alterations in human milk in simulated maternal nasal mucosal infection with live attenuated influenza vaccination
Document Type
article
Source
Mucosal Immunology. 15(5)
Subject
Medical Microbiology
Biomedical and Clinical Sciences
Clinical Sciences
Influenza
Pediatric
Emerging Infectious Diseases
Prevention
Immunization
Infectious Diseases
Vaccine Related
Biodefense
Nutrition
Pneumonia & Influenza
3.4 Vaccines
2.1 Biological and endogenous factors
Aetiology
Prevention of disease and conditions
and promotion of well-being
Inflammatory and immune system
Infection
Good Health and Well Being
Antibodies
Viral
Humans
Infant
Influenza Vaccines
Influenza
Human
Milk
Human
Nasal Mucosa
Vaccination
Vaccines
Attenuated
Vaccines
Inactivated
Biological Sciences
Medical and Health Sciences
Immunology
Language
Abstract
Breastfeeding protects against mucosal infections in infants. The underlying mechanisms through which immunity develops in human milk following maternal infection with mucosal pathogens are not well understood. We simulated nasal mucosal influenza infection through live attenuated influenza vaccination (LAIV) and compared immune responses in milk to inactivated influenza vaccination (IIV). Transcriptomic analysis was performed on RNA extracted from human milk cells to evaluate differentially expressed genes and pathways on days 1 and 7 post-vaccination. Both LAIV and IIV vaccines induced influenza-specific IgA that persisted for at least 6 months. Regulation of type I interferon production, toll-like receptor, and pattern recognition receptor signaling pathways were highly upregulated in milk on day 1 following LAIV but not IIV at any time point. Upregulation of innate immunity in human milk may provide timely protection against mucosal infections until antigen-specific immunity develops in the human milk-fed infant.